Alerts will be sent to your verified email
Verify Email
WELCURE
|
Welcure Drugs&Pharma
|
Dhariwalcorp
|
Standard Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
58.66 % | 49.88 % | 45.33 % |
|
5yr average Equity Multiplier
|
-0.69 | 5.76 | -2.49 |
|
5yr Average Asset Turnover Ratio
|
0.59 | 10.79 | 0.42 |
|
5yr Avg Net Profit Margin
|
-73.67 % | 1.06 % | -3.87 % |
|
Price to Book
|
1.18 | 0.0 | 0.93 |
|
P/E
|
63.25 | 26.46 | 130.25 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 13.06 Days | 562.29 Days |
|
Inventory Days
|
20.66 Days | 5.85 Days | 17.75 Days |
|
Days Receivable
|
1232.42 Days | 15.0 Days | 605.94 Days |
|
Days Payable
|
0.0 | 10.62 Days | 185.91 Days |
|
5yr Average Interest Coverage Ratio
|
-2.67 | 6.46 | 10.92 |
|
5yr Avg ROCE
|
8.46 % | 66.08 % | 16.96 % |
|
5yr Avg Operating Profit Margin
|
-73.54 % | 1.06 % | -55.75 % |
|
5 yr average Debt to Equity
|
-0.59 | 2.15 | -0.63 |
|
5yr CAGR Net Profit
|
-37.48 % | 26.0 % | -68.22 % |
|
5yr Average Return on Assets
|
13.61 % | 11.58 % | 14.76 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 73.67 % | 20.31 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.12 % | 0.18 % | 0.16 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Welcure Drugs&Pharma
|
Dhariwalcorp
|
Standard Inds
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|